This trial is active, not recruiting.

Condition postoperative complications
Treatment elective cardiac surgery
Sponsor RWTH Aachen University
Start date July 2015
End date November 2016
Trial size 100 participants
Trial identifier NCT02631304, 15-162


The purpose of this study is to assess the association between the "point-of-care" (POC) measured ChE activity (Acetylcholinesterase (ChE) + Buturylcholinesterase (ChE)) and postoperative delirium in elderly patients undergoing cardiac surgery.

Furthermore the investigators aim to identify factors, which influence the baseline levels and the time course of ChE activity.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Elderly patients scheduled to undergo elective cardiac surgery (coronary artery bypass graft (CABG), valve surgery, combined CABG-valve surgery) with the use of cardiopulmonary bypass.
elective cardiac surgery
Coronary artery bypass graft (CABG), valve surgery, combined CABG-valve surgery

Primary Outcomes

Acetylcholinesterase (AChE) and buturylcholinesterase (BuChE) activity
time frame: 5 days
time frame: 5-45 days

Secondary Outcomes

Pre-existing patient related risk factors
time frame: 1 day
Identification of anticholinergic concomitant medication according to the PRISCUS list
time frame: 1 day
Survey of treatment associated data
time frame: 45 days
Cognitive function
time frame: 45 days
Routine venous blood parameters
time frame: 5 days
Inflammatory markers
time frame: 5 days
Follow up measure of functional decline according to the IADL scale
time frame: 180 days
Follow up measure of mortality
time frame: 180 days
Follow up measure of the number of MACCE-events
time frame: 180 days
Health related quality of life
time frame: 180 days
Instrumental activities of daily living
time frame: 180 days

Eligibility Criteria

Male or female participants at least 65 years old.

Inclusion Criteria: - Written informed consent - ≥ 65 years of age - Scheduled to undergo elective cardiac surgery (coronary artery bypass graft (CABG), valve surgery, combined CABG-valve surgery) with the use of CPB - Both genders Exclusion Criteria: - Planned deep hypothermic arrest - Acute / emergency procedures - Surgery without extracorporeal circulation (ECC) - Patients with a history of pseudocholinesterase deficiency - Employees of the respective study centres - Illiteracy - Severe communication difficulties and severe vision or hearing problems - Patients legally unable to give written informed consent - non-fluency in German language - Severe psychiatric or neuropsychiatric disorders - MMSE < 24 points, short geriatric depression scale (GDS) ≥ 10 points - Recent (<6 months) history of alcohol or drug abuse - The participation in a drug or device trial within the previous 30 days

Additional Information

Official title Delirium in Elderly Undergoing Cardiac Surgery and the Significance of CholinEsterase Activity Measured by Point of Care Method - a Prospective Observational Study
Principal investigator Ana Stevanovic, MD
Description Cardiac surgery in elderly patients is associated with serious complications, like increased morbidity, mortality and postoperative delirium with further hazardous consequences. The incidence of postoperative delirium in elderly is reported with a range from 36.6% - 54.9%. The pathophysiology of delirium is complex and the interaction of the cholinergic system and inflammation reaction is a relevant precipitant factor. It was suggested that there is a strong association between the perioperative plasma ChE activity and the inflammatory response in patients developing delirium. Patients showed a significant reduction of the total ChE activity after orthopaedic surgery, with significant lower pre- and postoperative values of AChE and BuChE and increased inflammatory response in patients developing postoperative delirium. It remains unclear if these results are applicable to other patient populations and which factors have influenced the low preoperative ChE levels. In patients suffering from a cardiac disease, a reduced total ChE respectively BuChE activity was significantly associated with mortality and long-term major adverse cardiovascular events. The investigators hypothesize that the ChE activity in peripheral blood can be used as a potential biomarker, to early detect patients at high risk for postoperative delirium.
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by RWTH Aachen University.